Jpmorgan Chase & CO X Biotech Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in X Biotech Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 30,185 shares of XBIT stock, worth $76,669. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,185
Previous 14,624
106.41%
Holding current value
$76,669
Previous $57,000
70.18%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XBIT
# of Institutions
53Shares Held
4.45MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$2.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA945KShares$2.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny551KShares$1.4 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$630,6050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA221KShares$560,5240.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $77.3M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...